| SC 13G | 2024-03-25 | INCYTE CORP | Merus N.V. | 4,004,544 | 6.9% | EDGAR |
| SC 13G/A | 2024-03-06 | FEDERATED HERMES, INC. | Merus N.V. | 2,297,700 | 4.0% | EDGAR |
| SC 13G/A | 2024-02-14 | BIOTECHNOLOGY VALUE FUND L P | Merus N.V. | 1,467,604 | 2.5% | EDGAR |
| SC 13G/A | 2024-02-14 | COMMODORE CAPITAL LP | Merus N.V. | 4,747,373 | 8.2% | EDGAR |
| SC 13G | 2024-02-14 | SAMLYN CAPITAL, LLC | Merus N.V. | 3,412,410 | 5.9% | EDGAR |
| SC 13G/A | 2024-02-12 | Flynn James E | Merus N.V. | 3,019,901 | 5.2% | EDGAR |
| SC 13G/A | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Merus N.V. | 2,009,403 | 3.5% | EDGAR |
| SC 13G/A | 2024-01-18 | FEDERATED HERMES, INC. | Merus N.V. | 3,637,309 | 6.3% | EDGAR |
| SC 13D/A | 2023-08-14 | INCYTE CORP | Merus N.V. | 4,004,544 | 6.9% | EDGAR |
| SC 13G/A | 2023-03-10 | FEDERATED HERMES, INC. | Merus N.V. | 2,138,700 | 4.6% | EDGAR |
| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | Merus N.V. | 1,577,931 | 3.4% | EDGAR |
| SC 13G/A | 2023-02-14 | BAKER BROS. ADVISORS LP | Merus N.V. | - | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | COMMODORE CAPITAL LP | Merus N.V. | 2,732,567 | 5.9% | EDGAR |
| SC 13G/A | 2023-02-10 | Flynn James E | Merus N.V. | 2,380,438 | 5.1% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | Merus N.V. | 3,690,352 | 8.0% | EDGAR |
| SC 13G/A | 2023-02-01 | FEDERATED HERMES, INC. | Merus N.V. | 3,924,295 | 8.5% | EDGAR |
| SC 13G | 2022-09-30 | Flynn James E | Merus N.V. | 2,521,553 | 5.5% | EDGAR |
| SC 13G | 2022-05-16 | COMMODORE CAPITAL LP | Merus N.V. | 2,242,224 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Merus N.V. | 2,203,079 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-14 | Boxer Capital, LLC | Merus N.V. | 1,900,000 | 4.4% | EDGAR |